Perhaps that is correct, Hy, in which case this would be a creative way of navigating the issue. Once the funding hurdle is cleared thru NGIO, Joe could rectify the Iliad case and open up the other options.
The picture may be getting clearer...
(1)
(0)
Generex Biotechnology Corp. (GNBTQ) Stock Research Links